Per NASDAQ our volume since Jan 1 2021 is 570,600,030 (in
Per NASDAQ our volume since Jan 1 2021 is 570,600,030 (in 14 months)
The shares some are quaking about have NOT been sold into the float.
Don't let anyone scare you into making a bad decision.
Changes coming as we all know.
Mar 12 - Filed annual report 3 weeks early
- Added Investor link to website
- message that lots has happened since Dec 31
Feb 18 - OTC Markets profile update. Added Company Officer, Director, and Securities Counsel.
Feb 11 - Website changes. Temp pictures removed. Waiting on links for services.
Feb 9 - 1st ever Joel Shoenfeld (previous UNVC CEO) tweet "Keep up the good work Dr. David"
Feb 8 - Bullet train tweet.
Feb 8 - Amazon announces nationwide telehealth rollout.
Feb 8 - Website pages visible with nice changes.
Feb 4 - Lords Worldwide RS 1:10 LRDSF
Feb 3 - OTC Markets profile multiple updates discovered
Feb 3 - BioRemedies announces new product line
Jan 26 - Website pages visible, still under construction.
Jan 25 - Transfer agent share structure change: 45.5 million from the 60.9 million finally reach DTC
Jan 21 - Website under construction
Jan 13 - "Rocky-The movie always been one of my favorite"
Jan 11 - Transfer agent share structure change: 60.09 million added to OS
Jan 10 - "All good but a process - agency's short on staff etc slow. So I won't tweet etc any more until more control over outside entities"
Dec 22 - Tweet: "Documents being prepared for signature. Delivery for a Happy New Year."
Nov 9 - New website reserved univechealth.org
Nov 5 - Dr Dalton on BOD of new company Kizmet Impact Capital
Nov 4 - New website reserved telehealthunivec.com
Nov 3 - FINRA pushed new company profile info to multiple brokerages/websites
Oct 31 - Time Organization now offering transitional housing (Doc's plan for wraparound services)
Oct 30 - Federal partnership in Baltimore ("I recently announced the beginning of Univec's business plan for 'Wraparound Services' in Maryland for the mental health and substance use disorder," said Dr. David Dalton)
Oct 30 - Outpatient clinic acquisition (from news: "including recently acquired community-based outpatient mental health centers" )
Oct 30 - Told someone "We are moving"
Oct 28 - 98 million shares less owned by Doc. No change in float. Not sold. For company transaction.
Oct 28 - BioRemediesMD partnership
Oct 28 - Told someone 8K in Q4 (this Q)
Oct 23 - Hinted that website changes are coming soon
Oct 22 - First SEC filing in 10 years (form 144). Shows intent to provide funds for UNVC growth on pending news
Oct 1 - Tweet "Next week a big week"
Sep 29 - PINK CURRENT following more than a decade being DARK
8
Univec Conglomerate Inc (UNVC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Top 5 Most Recently Viewed Articles
FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...
Continue Reading
Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....
Continue Reading
Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...
Continue Reading
EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...
Continue Reading
Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...
Continue Reading